Zdrowie i gospodarka · 08/01/2021

FDA Clears ARALEN Tablets for Sale, Citing Lack of Safety or Efficacy Concerns

The US Food and Drug Administration (FDA) has announced that it will not withdraw approval of ARALEN (Chloroquine Phosphate) oral tablets, 500 milligrams, and other related drug products due to concerns over their safety or effectiveness.